<DOC>
	<DOCNO>NCT00637819</DOCNO>
	<brief_summary>A pilot study evaluate efficacy safety leflunomide SLE patient active disease refractory cyclophosphamide</brief_summary>
	<brief_title>Leflunomide Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<criteria>Fulfill revise ACR criterion SLE either evidence active disease accord SLE Disease Activity Index ( SLEDAI ) Patients pregnant nursing woman , life threaten disease The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>